837855855	837855855	CD	B-NP	O
|	|	NNP	I-NP	O
WWMC	WWMC	NNP	I-NP	O
|	|	VBD	B-VP	O
10546984	10546984	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9076976	9076976	CD	B-NP	O
|	|	CC	I-NP	O
5/14/2007	5/14/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHRONIC	CHRONIC	NNP	I-NP	I-protein
OBSTRUCTIVE	OBSTRUCTIVE	NNP	I-NP	I-protein
PULMONARY	PULMONARY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/18/2007	10/18/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/18/2007	3/18/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
ADIL	ADIL	NN	B-NP	B-protein
,	,	,	O	O
ERIC	ERIC	NNP	B-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Briefly	Briefly	NNP	B-NP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
COPD	COPD	NN	B-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
past	past	JJ	I-NP	O
intubations	intubation	NNS	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
noncompliant	noncompliant	JJ	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
end-stomy	end-stomy	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
and	and	CC	O	O
wheezing	wheeze	VBG	B-VP	O
times	time	NNS	B-NP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
82	82	CD	B-NP	O
%	%	NN	I-NP	O
that	that	WDT	B-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
90s	90	NNS	I-NP	O
on	on	IN	B-PP	O
nonrebreather	nonrebreather	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
where	where	WRB	B-ADVP	I-DNA
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
and	and	CC	O	O
given	give	VBN	B-NP	O
prednisone	prednisone	NN	I-NP	O
and	and	CC	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
identified	identify	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
.	.	.	O	O

Ceftazidime	Ceftazidime	NN	B-NP	O
was	be	VBD	B-VP	O
later	later	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
quickly	quickly	RB	I-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ABG	ABG	NNP	I-NP	O
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
partial	partial	JJ	B-NP	O
CO2	CO2	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
4.9	4.9	CD	B-NP	O
that	that	WDT	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
gentle	gentle	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
6.4	6.4	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
undergo	undergo	VB	I-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
run	run	NN	I-NP	O
of	of	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
end-stomy	end-stomy	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
and	and	CC	I-NP	O
gout	gout	NN	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Avapro	Avapro	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
,	,	,	O	O
TriCor	TriCor	NN	B-NP	O
48	48	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
55	55	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
34	34	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NN	B-NP	O
8	8	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Singulair	Singulair	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
puffs	puff	NNS	I-NP	I-protein
p.r.n.	p.r.n.	RB	B-ADVP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
500/50	500/50	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
once	once	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	O	O
loratadine	loratadine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
30-pack-year	30-pack-year	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
current	current	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
five	five	CD	B-NP	O
drinks	drink	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
temperature	temperature	NN	I-NP	O
is	be	VBZ	B-VP	O
96	96	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
82	82	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
150/72	150/72	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
24	24	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
is	be	VBZ	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
good	good	JJ	B-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
but	but	CC	O	O
expiratory	expiratory	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
and	and	CC	O	O
prolonged	prolonged	JJ	B-NP	O
expiratory	expiratory	JJ	I-NP	O
phase	phase	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
and	and	CC	I-NP	O
bowel	bowel	JJ	I-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-cell_line
211	211	CD	I-NP	I-cell_line
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
3.5	3.5	CD	I-NP	I-protein
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.4	4.4	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
13.4	13.4	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
25.8	25.8	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
492	492	CD	B-NP	O
and	and	CC	O	O
INR	INR	NN	B-NP	B-protein
1.3	1.3	CD	I-NP	I-protein
.	.	.	O	O

Microbiology	Microbiology	NNP	B-NP	O
,	,	,	O	O
numerous	numerous	JJ	B-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
sputum	sputum	NN	B-NP	O
and	and	CC	O	O
urine	urine	NN	B-NP	O
cultures	culture	NNS	I-NP	O
are	be	VBP	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
and	and	CC	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
from	from	IN	B-PP	O
7/21	7/21	CD	B-NP	O
shows	show	VBZ	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
COPD	COPD	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
likely	likely	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
floor	floor	NN	I-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
DuoNeb	DuoNeb	NNP	B-NP	O
q.	q.	NNP	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
added	add	VBN	I-VP	O
q.	q.	RB	B-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
staggered	stagger	VBD	B-VP	O
with	with	IN	B-PP	O
DuoNeb	DuoNeb	NNP	B-NP	O
such	such	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
receiving	receive	VBG	I-VP	O
nebulizer	nebulizer	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
overnight	overnight	RB	B-ADVP	O
for	for	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Advair	Advair	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
were	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
from	from	IN	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
satting	satte	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
to	to	TO	B-VP	O
mid	mid	VB	I-VP	O
90s	90s	CD	B-NP	O
with	with	IN	B-PP	O
ambulatory	ambulatory	JJ	B-NP	O
sat	sat	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
continuing	continue	VBG	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
both	both	CC	B-PP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
at	at	IN	B-PP	O
length	length	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
going	go	VBG	B-VP	O
about	about	IN	B-PP	O
his	his	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
activities	activity	NNS	I-NP	O
wearing	wear	VBG	B-VP	O
his	his	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
was	be	VBD	B-VP	O
slowly	slowly	RB	I-VP	O
tapered	taper	VBN	I-VP	O
and	and	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
take	take	VB	I-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
starting	start	VBG	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
slow	slow	JJ	I-NP	O
approximately	approximately	RB	I-NP	O
2-week	2-week	JJ	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
clinically	clinically	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
auto-diuresed	auto-diurese	VBD	B-VP	O
1-2	1-2	CD	B-NP	O
liters	liter	NNS	I-NP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
days	day	NNS	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

Followup	Followup	NN	B-NP	O
was	be	VBD	B-VP	O
arranged	arrange	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
pulmonologist	pulmonologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Gering	Gering	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
inpatient	inpatient	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
at	at	IN	B-PP	O
length	length	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
extremely	extremely	RB	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
inpatient	inpatient	NN	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
therefore	therefore	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
VNA	VNA	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
inpatient	inpatient	NN	B-NP	O
vs	vs	CC	O	O
outpatient	outpatient	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
followup	followup	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
time	time	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
happened	happen	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
continued	continue	VBN	B-NP	O
auto-diuresis	auto-diuresis	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
flow	flow	NN	I-NP	O
state	state	NN	I-NP	O
as	as	IN	B-PP	O
result	result	NN	B-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
hypovolemia	hypovolemia	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Renal	Renal	JJ	I-NP	O
Team	Team	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
ARB	ARB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
held	hold	VBN	I-VP	O
but	but	CC	O	O
then	then	RB	B-VP	O
restarted	restart	VBD	I-VP	O
upon	upon	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

Per	Per	RBR	B-ADJP	O
renal	renal	JJ	I-ADJP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
BUN	BUN	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
steroid	steroid	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
had	have	VBD	B-VP	O
normalized	normalize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
or	or	CC	O	O
graft	graft	NN	B-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
near	near	JJ	I-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
for	for	IN	B-PP	O
vein	vein	NN	B-NP	O
mapping	mapping	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
receive	receive	VB	I-VP	O
blood	blood	NN	B-NP	O
draws	draw	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
of	of	IN	B-PP	O
avoidable	avoidable	JJ	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
Levaquin	Levaquin	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
completed	complete	VBD	B-VP	O
this	this	DT	B-NP	O
course	course	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
discharged	discharge	VBD	B-VP	O
off	off	RP	B-PRT	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
anti-lipidemics	anti-lipidemic	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Toprol	Toprol	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
medicines	medicine	NNS	I-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
changed	change	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
occasional	occasional	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
usually	usually	RB	I-NP	O
triplets	triplet	NNS	I-NP	O
or	or	CC	I-NP	O
couplets	couplet	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Vitro	Vitro	NNP	I-NP	O
insulin	insulin	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
increased	increase	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
ICU	ICU	NN	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADVP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
use	use	NN	I-NP	O
and	and	CC	I-NP	O
stress	stress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
fell	fall	VBD	B-VP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
preadmission	preadmission	NN	I-NP	O
levels	level	NNS	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
and	and	CC	I-NP	O
proton	proton	NN	I-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Heart	Heart	RB	B-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
without	without	IN	B-PP	O
wheezes	wheeze	NNS	B-NP	O
,	,	,	I-NP	O
rales	rale	NNS	I-NP	O
or	or	CC	I-NP	O
rhonchi	rhonchus	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
trace	trace	NN	B-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
see	see	VBP	B-VP	O
remainder	remainder	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
paperwork	paperwork	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
home	home	VB	I-VP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
both	both	CC	O	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
and	and	CC	I-NP	O
pulmonologist	pulmonologist	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
appointments	appointment	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
arranged	arrange	VBN	I-VP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-2153117	5-2153117	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Owen	Owen	NNP	B-NP	O
Augusto	Augusto	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Son	Son	NNP	I-NP	O
Aville	Aville	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Ville	Ville	NNP	I-NP	O
Sta	Sta	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Rosendo	Rosendo	NNP	B-NP	O
Waage	Waage	NNP	I-NP	O
MD	MD	NNP	I-NP	O
M	M	NNP	I-NP	O
CAAN	CAAN	NNP	I-NP	O
HEALTH	HEALTH	NNP	I-NP	O
Ton	Ton	NNP	I-NP	O
-	-	HYPH	B-NP	O
Veca	Veca	NNP	I-NP	O
Solos	Solos	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Lyman	Lyman	NNP	B-NP	O
Kea	Kea	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Ards	Ards	NNP	I-NP	O
Elk	Elk	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
No	No	NNP	I-NP	O
Spo	Spo	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
TIOTUICO	TIOTUICO	NNP	B-NP	O
,	,	,	O	O
RODNEY	RODNEY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TOWSE	TOWSE	NNP	B-NP	O
,	,	,	O	O
JEFF	JEFF	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6062399	6062399	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/26/07	10/26/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/26/07	10/26/07	CD	B-NP	O

